Edmonton-based Metabolomic Technologies Inc, a developer of metabolomics-based in-vitro diagnostics, has raised $4.2 million in Series A funding. The investors were not named.
Source: Press Release
Edmonton-based Metabolomic Technologies Inc, a developer of metabolomics-based in-vitro diagnostics, has raised $4.2 million in Series A funding. The investors were not named.
Source: Press Release
Copyright PEI Media
Not for publication, email or dissemination
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.